Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jul 26:14:1337815.
doi: 10.3389/fonc.2024.1337815. eCollection 2024.

Genetic profiling in radiotherapy: a comprehensive review

Affiliations
Review

Genetic profiling in radiotherapy: a comprehensive review

Dino Rubini et al. Front Oncol. .

Abstract

This comprehensive review explores the pivotal role of radiotherapy in cancer treatment, emphasizing the diverse applications of genetic profiling. The review highlights genetic markers for predicting radiation toxicity, enabling personalized treatment planning. It delves into the impact of genetic profiling on radiotherapy strategies across various cancer types, discussing research findings related to treatment response, prognosis, and therapeutic resistance. The integration of genetic profiling is shown to transform cancer treatment paradigms, offering insights into personalized radiotherapy regimens and guiding decisions in cases where standard protocols may fall short. Ultimately, the review underscores the potential of genetic profiling to enhance patient outcomes and advance precision medicine in oncology.

Keywords: genomic profiling; profiling; radiation oncology (RO); radiogenomics; radiotherapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

References

    1. Alaeikhanehshir S, Ajayi T, Duijnhoven FH, Poncet C, Olaniran RO, Lips EH, et al. . Locoregional breast cancer recurrence in the european organisation for research and treatment of cancer 10041/BIG 03-04 MINDACT trial: analysis of risk factors including the 70-gene signature. J Clin oncology: Off J Am Soc Clin Oncol. (2024) 10:Jco2202690. doi: 10.1200/JCO.22.02690 - DOI - PubMed
    1. Tramm T, Mohammed H, Myhre S, Kyndi M, Alsner J, Børresen-Dale AL, et al. . Development and validation of a gene profile predicting benefit of postmastectomy radiotherapy in patients with high-risk breast cancer: a study of gene expression in the DBCG82bc cohort. Clin Cancer research: an Off J Am Assoc Cancer Res. (2014) 20:5272–80. doi: 10.1158/1078-0432.CCR-14-0458 - DOI - PubMed
    1. Sjöström M, Chang SL, Fishbane N, Davicioni E, Zhao SG, Hartman L, et al. . Clinicogenomic radiotherapy classifier predicting the need for intensified locoregional treatment after breast-conserving surgery for early-stage breast cancer. J Clin oncology: Off J Am Soc Clin Oncol. (2019) 37:3340–9. doi: 10.1200/JCO.19.00761 - DOI - PMC - PubMed
    1. Sjöström M, Fyles A, Liu FF, McCready D, Shi W, Rey-McIntyre K, et al. . Development and validation of a genomic profile for the omission of local adjuvant radiation in breast cancer. J Clin oncology: Off J Am Soc Clin Oncol. (2023) 41:Jco2200655. doi: 10.1200/JCO.22.00655 - DOI - PMC - PubMed
    1. Scott JG, Berglund A, Schell MJ, Mihaylov I, Fulp WJ, Yue B, et al. . A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study. Lancet Oncol. (2017) 18:202–11. doi: 10.1016/S1470-2045(16)30648-9 - DOI - PMC - PubMed

LinkOut - more resources